<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Type of First Recurrence (CoC)</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1880</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2206-2207</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Code for the type of first recurrence after a period of documented disease free intermission or remission.

<br/><br/><b>Codes</b><br/>
<table class="naaccr-codes-table">
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">00</td>
        <td class="naaccr-codes-cell">Patient became disease-free after treatment and has not had a recurrence; leukemia in remission.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">04</td>
        <td class="naaccr-codes-cell"><i>In situ</i> recurrence of an invasive tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">06</td>
        <td class="naaccr-codes-cell"><i>In situ</i> recurrence of an <i>in situ</i> tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">10</td>
        <td class="naaccr-codes-cell">Local recurrence and there is insufficient information available to code to 13-17. Recurrence is confined to the remnant of the organ of origin; to the organ of origin; to the anastomosis; or to scar tissue where the organ previously existed.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">13</td>
        <td class="naaccr-codes-cell">Local recurrence of an invasive tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">14</td>
        <td class="naaccr-codes-cell">Trocar recurrence of an invasive tumor. Includes recurrence in the trocar path or entrance site following prior surgery.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">15</td>
        <td class="naaccr-codes-cell">Both local and trocar recurrence of an invasive tumor (both 13 and 14)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">16</td>
        <td class="naaccr-codes-cell">Local recurrence of an <i>in situ</i> tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">17</td>
        <td class="naaccr-codes-cell">Both local and trocar recurrence of an <i>in situ</i> tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">20</td>
        <td class="naaccr-codes-cell">Regional recurrence, and there is insufficient information available to code to 21-27.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">21</td>
        <td class="naaccr-codes-cell">Recurrence of an invasive tumor in adjacent tissue or organ(s) only.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">22</td>
        <td class="naaccr-codes-cell">Recurrence of an invasive tumor in regional lymph nodes only.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">25</td>
        <td class="naaccr-codes-cell">Recurrence of an invasive tumor in adjacent tissue or organ(s) and in regional lymph nodes (both 21 and 22) at the same time.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">26</td>
        <td class="naaccr-codes-cell">Regional recurrence of an <i>in situ</i> tumor, NOS.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">27</td>
        <td class="naaccr-codes-cell">Recurrence of an <i>in situ</i> tumor in adjacent tissue or organ(s) and in regional lymph nodes at the same time.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">30</td>
        <td class="naaccr-codes-cell">Both regional recurrence of an invasive tumor in adjacent tissue or organ(s) and/or regional lymph nodes (20-25) and local and/or trocar recurrence (10, 13, 14, or 15).</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">36</td>
        <td class="naaccr-codes-cell">Both regional recurrence of an <i>in situ</i> tumor in adjacent tissue or organ(s) and/or regional lymph nodes (26 or 27) and local and/or trocar recurrence (16 or 17).</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">40</td>
        <td class="naaccr-codes-cell">Distant recurrence and there is insufficient information available to code to 46-62.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">46</td>
        <td class="naaccr-codes-cell">Distant recurrence of an <i>in situ</i> tumor.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">51</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">52</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">53</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">54</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the liver only.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">55</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">56</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">57</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">58</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">59</td>
        <td class="naaccr-codes-cell">Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, and generalized disease.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">60</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar, and/or regional recurrence (10-15, 20-25, or 30).</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">62</td>
        <td class="naaccr-codes-cell">Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">70</td>
        <td class="naaccr-codes-cell">Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">88</td>
        <td class="naaccr-codes-cell">Disease has recurred, but the type of recurrence is unknown.</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">99</td>
        <td class="naaccr-codes-cell">It is unknown whether the disease has recurred or if the patient was ever disease-free.</td>
    </tr>
</table>
